OPKO Health raised its 2026 revenue forecast to $560M-$585M after surpassing Q2 estimates on both revenue and earnings.
OPKO Health (OPK) increased its full-year 2026 revenue guidance to $560M-$585M, up from the prior $520M-$560M range. The revised outlook follows stronger-than-expected Q2 results, with both revenue and earnings exceeding analyst expectations.
Consensus estimates for 2026 had stood at $536.88M, while Q3 revenue projections of $131M-$142M slightly bracket the $134.65M consensus. The company’s performance reflects improved operational execution and demand for its products.
Shares of OPK surged approximately 19% in after-hours trading following the announcement, signaling investor confidence in the revised outlook.